ARCHIVES

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

March 9, 1990

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications

January 31, 2014

OAM Director Jacobs To Leave; Cites “Conflict with Conscience”

July 15, 1994

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004